Long-term results of intraoperative electron beam radiotherapy for primary and recurrent retroperitoneal soft tissue sarcoma

Int J Radiat Oncol Biol Phys. 2001 May 1;50(1):127-31. doi: 10.1016/s0360-3016(00)01589-3.

Abstract

Purpose: This study assesses the long-term outcome of patients with retroperitoneal sarcoma treated by preoperative external beam radiotherapy, resection, and intraoperative electron beam radiation (IOERT).

Methods and materials: From 1980 to 1996, 37 patients were treated with curative intent for primary or recurrent retroperitoneal soft tissue sarcoma. All patients underwent external beam radiotherapy with a median dose of 45 Gy. This was followed by laparotomy, resection, and IOERT, if feasible. Twenty patients received 10-20 Gy of IOERT with 9-15 MeV electrons. These patients were compared to a group of 17 patients receiving preoperative irradiation without IOERT.

Results: The 5-yr actuarial overall survival (OS), disease-free survival, local control (LC), and freedom from distant disease of all 37 patients was 50%, 38%, 59%, and 54%, respectively. After preoperative irradiation, 29 patients (78%) underwent gross total resection. For 16 patients undergoing gross total resection and IOERT, OS and LC were 74% and 83%, respectively. In contrast, these results were less satisfactory for 13 patients undergoing gross total resection without IOERT. For these patients, OS and LC were 30% and 61%, respectively. Four patients experienced treatment-related morbidity.

Conclusions: In selected patients, IOERT results in excellent local control and disease-free survival with acceptable morbidity.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Child
  • Combined Modality Therapy
  • Disease-Free Survival
  • Electrons
  • Female
  • Humans
  • Intraoperative Care
  • Male
  • Middle Aged
  • Radiotherapy / adverse effects
  • Retroperitoneal Neoplasms / radiotherapy*
  • Retroperitoneal Neoplasms / surgery
  • Sarcoma / radiotherapy*
  • Sarcoma / surgery
  • Soft Tissue Neoplasms / radiotherapy*
  • Soft Tissue Neoplasms / surgery
  • Survival Rate
  • Treatment Outcome